Ronald Liu
Contributor since: 2017
Latest Articles
Amazon Increases Price Of Monthly Prime Memberships - Why Not?
Merck Has Strong Conviction In KalVista's Phase 2 Clinical Trial Of KVD001 In DME
Bristol-Myers Squibb's Abatacept Compared Against Aurinia Pharmaceuticals' Voclosporin In The Treatment Of Lupus Nephritis Patients
Amazon's Pharmacy Licenses Threaten CVS Health
Tesla's Model 3 Vehicle Expectations - Do You Believe?
Dear General Electric Investors, Please Learn From Teva Pharmaceutical's Complications
Teva's Ongoing Complications: Psychology And Generic Drugs
Micron's $1 Billion Dilution: Cons Outweigh The Pros
Google Expands In The Smart Home Business By Introducing The Home Mini
GlaxoSmithKline's New Self-Injectable Formulation Of Benlysta Makes Sense
Forget The iPhone, Apple's Artificial Intelligence Is The Real Deal
Zogenix: Investors Bet Heavy On ZX008 For Dravet Syndrome
AbbVie Should Obtain FDA Approval For Elagolix
Did Tesla Just Ditch Nvidia For Advanced Micro Devices?
Aurinia Pharmaceuticals Patent Analysis: An Interview With The COO
Gilead's Acquisition Of Kite Pharma Relieves Shareholders' Ennui
AVEO's European Commission Approval Is Official
KEMET Corporation's 180 Degree Transformation
Gilead's Unique Philanthropic Act Will Pay Off
Aurinia Pharmaceuticals: Phase III Design Gleaned From Phase II Study